Literature DB >> 6661641

Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.

R J Rylett, M J Ball, E H Colhoun.   

Abstract

Sodium-dependent, hemicholinium-sensitive choline transport was measured in purified synaptosomes prepared from fresh necropsy brain of patients with senile dementia of the Alzheimer type and from control subjects. Choline transport velocity was standardized in terms of the occluded lactate dehydrogenase activity of the various synaptosomal preparations, rather than in terms of the protein content, since this enzyme is more representative of the synaptosome content of the purified homogenates. A regional difference in high-affinity choline transport was observed in purified synaptosomes prepared from brains of mentally normal controls; the velocities of sodium-dependent and hemicholinium-sensitive choline uptake into synaptosomes from hippocampus were about twice as great as that into synaptosomes from frontal cortex, indicating a greater relative density of cholinergic innervation in the hippocampus. Hippocampal and neocortical cholinergic nerve cell endings, prepared as synaptosomes, from brains of patients with Alzheimer's disease, also accumulated choline by a high-affinity mechanism; however, the velocity of uptake into both brain areas was decreased in comparison with controls. Choline transport into synaptosomes from Alzheimer frontal cortex was reduced approximately 50%, while uptake into Alzheimer hippocampal synaptosomes represented only 20% of the control activity. The reduction in synaptosomal high-affinity choline transport in Alzheimer's disease could be indicative of degeneration of cholinergic nerve terminal boutons resulting from cholinergic nerve cell death, or could result from an overall decrease in the number of carrier sites per nerve terminal or in the carrier transport velocity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661641     DOI: 10.1016/0006-8993(83)90017-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  30 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.

Authors:  Cassia R Overk; Christian C Felder; Yuan Tu; Doug A Schober; Kelly R Bales; Joanne Wuu; Elliott J Mufson
Journal:  J Chem Neuroanat       Date:  2010-03-27       Impact factor: 3.052

3.  Studies on choline transport enhancement into fibroblasts from normals and Alzheimer's donors.

Authors:  L C Mokrasch
Journal:  Neurochem Res       Date:  1991-07       Impact factor: 3.996

Review 4.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Galanin-like immunoreactivity within Ch2 neurons in the vertical limb of the diagonal band of Broca in aging and Alzheimer's disease.

Authors:  O J Vogels; K Renkawek; C A Broere; H J ter Laak; F van Workum
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level.

Authors:  L Nilsson; A Nordberg; J Hardy; P Wester; B Winblad
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 7.  Pathogenesis of Alzheimer's disease--beyond the cholinergic hypothesis: discussion paper.

Authors:  P J Harrison
Journal:  J R Soc Med       Date:  1986-06       Impact factor: 5.344

Review 8.  The role of synaptic microRNAs in Alzheimer's disease.

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-08-20       Impact factor: 5.187

9.  Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.

Authors:  T A Slotkin; C B Nemeroff; G Bissette; F J Seidler
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  MKC-231, a choline uptake enhancer: (2) Effect on synthesis and release of acetylcholine in AF64A-treated rats.

Authors:  Ken Takashina; Tomoko Bessho; Reiko Mori; Junichi Eguchi; Ken-Ichi Saito
Journal:  J Neural Transm (Vienna)       Date:  2008-04-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.